 |
市場調查報告書
商品編碼
2114212
產前篩檢市場：細分市場規模、佔有率、監理、保險報銷狀況及至2036年預測Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
「產前篩檢市場 - 細分市場規模、佔有率、監管、保險報銷狀況及至 2036 年的預測」旨在可視化體外診斷 (IVD) 治療領域的定量和定性市場趨勢。
產前篩檢是指利用各種檢體採集技術（從微創到高度侵入性）來檢測可能影響胎兒存活和發育的問題。目前，在已開發國家，產前篩檢已成為常規檢查手段，用於早期發現染色體異常和神經管缺陷（NTDs）。在大多數國家，母體血清篩檢和超音波檢查已成為篩檢孕婦染色體異常和其他先天性異常的標準程序。
針對39個目標國家，採用顏色編碼、資料來源參考的市場模型納入了以流行病學為基礎的適應性資訊。互動式Excel格式的交付成果涵蓋貨幣價值、數量、產品使用、平均售價、市場規模和企業市場占有率分析（如有）。此外，分析師評論（包括定性見解）為定量數據提供了背景資訊。
市場模式的主要組成如下：
目前市場上的產前篩檢以及不斷變化的競爭格局。
- 對關鍵產業趨勢的深刻剖析。
- 2015 年至 2036 年產前篩檢市場各細分領域的年度總收入及市場展望。
- 市場層級的數據，包括銷售量、平均售價和市場規模。
全球、區域和國家層面的具體市場洞察。
- 報告提供針對特定市場的定性訊息，並將全球趨勢進一步細分為區域趨勢。此外，GlobalData 分析師還提供獨特的、針對特定國家的市場洞察。
- 對產前篩檢市場進行SWOT分析。
- 產前篩檢市場競爭考察及發展趨勢。
透過獲得真正全面的整體情況，包括對醫療保健系統的概述，您可以加深對市場的理解。此外，在「市場進入」部分，您可以利用有關報銷政策和監管條件的信息，更深入地了解市場動態。
- 各國醫療保健系統概覽。
- 各國具體的還款政策。
- 各國關於醫療技術的法規。
憑藉嚴謹的調查方法和資料來源，該模型能夠提供全面且精準的市場概覽。企業聯合組織模型整合了來自需求方和供應方的一級資訊來源，包括關鍵意見領袖（KOL）的觀點。此外，它還利用真實世界的資料來源來捕捉市場趨勢，例如政府手術資料庫、醫院採購資料庫和專有線上資料庫。
目標公司：Illumina Inc.、華大基因股份有限公司、Yourgene Health Plc、Eurofins Scientific SE、Agilent Technologies Inc.、Roche Diagnostics International Ltd、Revvity Inc.、Beckman Coulter Inc.、Abbott Laboratories、Siemens Healthineers AG、Quidel Corp.、Themot、 Fisher Scients Corp. 等。
目標國家：美國、英國、德國、法國、義大利、西班牙、巴西、中國、印度、俄羅斯、日本、澳洲、加拿大、墨西哥、韓國、丹麥、愛爾蘭、荷蘭、紐西蘭、南非、瑞典、瑞士、奧地利、比利時、芬蘭、以色列、挪威、波蘭、葡萄牙、台灣、捷克、希臘、匈牙利、土耳其、埃及、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷、智利。
調查範圍
這個市場模型提供了其他任何資訊來源都無法獲得的關鍵專家見解。它揭示了目標市場的定性和定量趨勢。以下人群必須閱讀此模型：
- 對於需要深入了解產前篩檢市場以製定策略計劃和投資決策的首席行銷長 (CMO) 而言。
- 採購負責人需要了解供應基礎的關鍵要素，以便做出有關供應商選擇和管理的決策。
- 私募股權投資者需要對市場有更深入的了解，才能發現潛在的投資機會並評估其價值。
購買原因
利用這種模型，可以實現以下目標：
- 透過識別關鍵公司並仔細審查其開發平臺，您可以製定和設計引入授權許可和對外授權策略。
- 您將能夠了解影響和推動產前篩檢市場的趨勢，並制定商業策略。
- 透過了解關鍵趨勢、創新產品和技術、市場細分以及未來可能影響產前篩檢市場的公司，您可以增加收入。
- 透過了解競爭格局並分析領導企業的市場佔有率，您可以製定有效的銷售和行銷策略。
- 您可以識別出擁有強大產品系列的新興企業，並制定有效的應對策略以獲得競爭優勢。
- 本報告追蹤了 2015 年至 2036 年全球及各國產前篩檢醫療設備市場的銷售趨勢。
- 我們確定在整合、投資和策略聯盟方面最具機會的市場類別和細分市場，然後據此系統化我們的銷售和行銷活動。
Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.
Prenatal screening describes tests that detect potential problems that affect the viability and development of the fetus using both less invasive and more invasive sampling techniques. Prenatal Screening is now routinely used in developed countries for early detection of chromosomal abnormalities and NTDs.In most countries, maternal serum screening and ultrasound remain standard-of-care for screening of pregnant women for chromosome aneuploidies and other birth defects.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Prenatal Screening and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Prenatal Screening market revenue by segment and market outlooks from 2015-2036.
- Market level data on units, average selling prices and market values.
Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Prenatal Screening market.
- Competitive dynamics insights and trends provided for Prenatal Screening market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Illumina Inc, BGI Genomics Co Ltd, Yourgene Health Plc, Eurofins Scientific SE, Agilent Technologies Inc, Roche Diagnostics International Ltd, Revvity Inc, Beckman Coulter Inc, Abbott Laboratories, Siemens Healthineers AG, Quidel Corp, Thermo Fisher Scientific Inc, Tosoh Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the Prenatal Screening market place to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Prenatal Screening market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Prenatal Screening market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Prenatal Screening market from 2015-2036.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
